Low-Dose Naltrexone: Understanding Its Use in Fibromyalgia
How LDN is being explored for fibromyalgia pain, what the early research shows, and what to discuss with your provider.
Low-dose naltrexone (LDN) is increasingly being explored as a potential option for fibromyalgia, a chronic pain condition. This article looks at how LDN is used for fibromyalgia in current research and practice, and what patients should know before discussing it with a provider.
What Is Low-Dose Naltrexone?
Naltrexone is traditionally used at higher doses to treat opioid and alcohol use disorders by blocking opioid receptors in the brain. At much lower doses — typically around 4.5 mg daily — naltrexone is being studied for potential anti-inflammatory and pain-modulating effects that may benefit certain chronic pain conditions, including fibromyalgia.
How LDN Is Being Explored for Fibromyalgia
Using LDN for fibromyalgia is considered off-label, meaning it has not been approved by regulatory agencies for this specific use. The interest is based on emerging research suggesting LDN may help reduce fibromyalgia-related pain in some patients. LDN is thought to modulate the activity of microglial cells in the central nervous system, which may play a role in inflammation and pain — though this mechanism is not yet fully understood.
💡 In one small clinical trial of women with fibromyalgia, a majority reported a reduction in pain while taking LDN compared to placebo. LDN was also generally well-tolerated, though research remains limited by small sample sizes.
Current Limitations to Keep in Mind
The use of LDN for fibromyalgia is still considered experimental. Existing studies are limited by small sample sizes and a lack of standardized treatment protocols, so more extensive clinical trials are needed to confirm its long-term efficacy and safety. Patients considering LDN should understand that its exact mechanism in fibromyalgia is still being studied, and results can vary from person to person.
- Discuss the potential benefits and risks of LDN with your provider
- Ask about the current state of research and any recent developments
- Consider your overall health, current medications, and other conditions that could affect suitability
LDN requires a prescription from a licensed provider and, because it is not commercially available at these doses, must be prepared by a compounding pharmacy. Sierra Compounding Pharmacy prepares LDN formulations for patients throughout the Inland Empire when prescribed.
Frequently Asked Questions
Sierra Compounding Pharmacy Can Help
All compounded medications require a valid prescription from a licensed healthcare provider. If your provider has determined that a customized compounded formulation is appropriate for your needs, Sierra Compounding Pharmacy — located in Rancho Cucamonga — is here to help. We serve patients throughout the Inland Empire, including San Bernardino County, Riverside County, and surrounding communities.
Related Education Articles
What Is Low Dose Naltrexone (LDN)?
An educational overview of LDN compounding and what patients should know before speaking with their provider.
Weight Management and Compounding Pharmacy Support
How personalized compounded medications may support provider-directed weight management plans.
Custom Dermatology Compounding: What Patients Should Know
How personalized topical formulations may support dermatology and aesthetic prescription needs.
Questions About Compounded Medications?
Sierra Compounding Pharmacy serves patients and providers throughout the Inland Empire. Contact us or ask your provider to send a prescription directly.